US EditionCosette Pharmaceuticals to acquire Mayne Pharma for $430M | North Carolina Biotechnology Center
Summary by ncbiotech.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Cosette Pharmaceuticals to acquire Mayne Pharma for $430M | North Carolina Biotechnology Center
Two pharmaceutical companies with operations in North Carolina are joining forces for a greater impact on women’s health.Cosette Pharmaceuticals, based in Bridgewater, N.J., with a pharmaceutical production plant in Lincolnton, N.C., will acquire the Australian pharmaceutical company Mayne Pharma Group, which has its U.S. headquarters in Raleigh. Cosette will pay about $430 million for Mayne, or $7.40 Australian per share.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
